Sangamo Therapeutics News and Activities

Sangamo Therapeutics is a company listed under the stock ticker SGMO (US).

View the org chart displaying its 22 main executives

Most searched biographies at Sangamo Therapeutics

• Sandy Macrae, Director, President and Chief Executive Officer
• Robert Carey, Director
• Karen Smith, Director

Popular executive movements at Sangamo Therapeutics

• Nikunj Jain has joined the company as Vice President, Finance and Corporate Controller  (posted on October 1 2025).
• Prathyusha Duraibabu, Senior Vice President and Chief Financial Officer, will leave the company on Oct. 1, 2025  (posted on September 12 2025).

Create your alert
to follow the executive moves at Sangamo Therapeutics.

Sangamo Therapeutics has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Corden Pharma has announced the acquisition of AmbioPharm  (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Sangamo Therapeutics

• Sangamo Therapeutics Announces Second Quarter 2022 Conference Call and Webcast | Sangamo Therapeutics, Inc.
• European Orphan Medicinal Product Designation Granted to Sangamo Therapeutics Investigational CAR-Treg Cell Therapy TX200 for Solid Organ Transplantation | Sangamo Therapeutics, Inc.
• News Releases | Sangamo Therapeutics, Inc.
• News Releases | Sangamo Therapeutics, Inc.
• Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences | Sangamo Therapeutics, Inc.
• Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results | Sangamo Therapeutics, Inc.
• Sangamo Therapeutics to Present Data From Its Next-Generation Technologies at 2022 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) | Sangamo Therapeutics, Inc.
• Sangamo Therapeutics Announces First Quarter 2022 Conference Call and Webcast | Sangamo Therapeutics, Inc.
• News Releases | Investor Relations | Sangamo Therapeutics, Inc.
• Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment | Sangamo Therapeutics, Inc.
• View more press releases Close

Social media about Sangamo Therapeutics

• Sangamo Therapeutics on Wikipedia, Google News & Yahoo Finance
• Sangamo Therapeutics on LinkedIn, X (Twitter) & YouTube